The Global E-coli Testing Market size is expected to reach $3.1 billion by 2031, rising at a market growth of 6.3% CAGR during the forecast period.
North America has experienced notable outbreaks of food-borne illnesses linked to E-coli contamination in foods like ground beef, leafy greens, and other produce. This has heightened the demand for routine E-coli testing in the food industry to prevent outbreaks and protect public health. The region has a well-developed healthcare infrastructure with numerous hospitals, clinics, and diagnostic laboratories equipped with advanced diagnostic technologies. The high healthcare delivery and diagnostic testing capacity contributes to the significant demand for E-coli testing. Thus, the North America region segment acquired 39% revenue share in the market 2023.
Personalized medicine approaches involve close monitoring and management for individuals with chronic or recurrent E-coli infections. Advanced E-coli testing technologies enable regular and detailed assessment of infection status, allowing for personalized treatment and adjustments to management strategies.
Additionally, companies continuously develop and introduce new products as the food and beverage industry grows. Each new product requires rigorous testing to ensure it is free from E-coli and other contaminants. This demand for safety in new product lines contributes to the growth of the E-coli testing market. Therefore, the growing food and beverage industry is driving growth.
However, advanced testing technologies, such as molecular diagnostics (e.g., PCR), next-generation sequencing (NGS), and automated systems, often require substantial financial investment. This includes costs for purchasing equipment, maintaining and calibrating it, and training personnel to use it effectively.
North America has experienced notable outbreaks of food-borne illnesses linked to E-coli contamination in foods like ground beef, leafy greens, and other produce. This has heightened the demand for routine E-coli testing in the food industry to prevent outbreaks and protect public health. The region has a well-developed healthcare infrastructure with numerous hospitals, clinics, and diagnostic laboratories equipped with advanced diagnostic technologies. The high healthcare delivery and diagnostic testing capacity contributes to the significant demand for E-coli testing. Thus, the North America region segment acquired 39% revenue share in the market 2023.
Personalized medicine approaches involve close monitoring and management for individuals with chronic or recurrent E-coli infections. Advanced E-coli testing technologies enable regular and detailed assessment of infection status, allowing for personalized treatment and adjustments to management strategies.
Additionally, companies continuously develop and introduce new products as the food and beverage industry grows. Each new product requires rigorous testing to ensure it is free from E-coli and other contaminants. This demand for safety in new product lines contributes to the growth of the E-coli testing market. Therefore, the growing food and beverage industry is driving growth.
However, advanced testing technologies, such as molecular diagnostics (e.g., PCR), next-generation sequencing (NGS), and automated systems, often require substantial financial investment. This includes costs for purchasing equipment, maintaining and calibrating it, and training personnel to use it effectively.
Driving and Restraining Factors
Drivers
- Increased focus on personalized medicine
- Growing food and beverage industry
- Increasing incidence of E-coli infections
Restraints
- High costs of advanced testing technologies
- Complexity and technical challenges
Opportunities
- Expansion tourism and hospitality industry
- Rise of home testing kits
Challenges
- Shortage and lack of skilled personnel
- Challenges in sample collection and handling
End-Use Outlook
On the basis of end user, the market is segmented into hospitals, diagnostic laboratories, and physicians’ offices. In 2023, the diagnostic laboratories segment attained 43% revenue share in the market. Hospitals experience a high volume of patients with diverse medical conditions, increasing the likelihood of encountering E-coli infections.Test Outlook
Based on the test, the market is divided into environmental test and clinical test. The clinical test segment witnessed 32% revenue share in the market in 2023. E-coli-related infections are increasing, including urinary tract infections (UTIs), bloodstream infections, and gastrointestinal illnesses.Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 25% revenue share in the market. The Asia Pacific region is experiencing rapid urbanization and industrialization, which can lead to increased pollution and contamination of water sources.List of Key Companies Profiled
- BIOMÉRIEUX
- Bio-Rad Laboratories, Inc.
- Pro Lab diagnostics
- NanoLogix, Inc.
- Thermo Fisher Scientific
- CPI International
- Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
- Becton, Dickinson and Company
- IDEXX Laboratories, Inc.
Market Report Segmentation
By Test
- Environmental Test
- Clinical Test
By End User
- Diagnostic Laboratories
- Hospitals
- Physicians Offices
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Global E-coli Testing Market by Test
Chapter 5. Global E-coli Testing Market by End User
Chapter 6. Global E-coli Testing Market by Region
Chapter 7. Company Profiles
Companies Mentioned
- BIOMÉRIEUX
- Bio-Rad Laboratories, Inc.
- Pro Lab diagnostics
- NanoLogix, Inc.
- Thermo Fisher Scientific
- CPI International
- Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
- Becton, Dickinson and Company
- IDEXX Laboratories, Inc.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 161 |
Published | August 2024 |
Forecast Period | 2023 - 2031 |
Estimated Market Value ( USD | $ 1.92 Billion |
Forecasted Market Value ( USD | $ 3.1 Billion |
Compound Annual Growth Rate | 6.3% |
Regions Covered | Global |
No. of Companies Mentioned | 9 |